Amin Rostami-Hodjegan
Manchester University
H-index: 81
North America-United States
Top articles of Amin Rostami-Hodjegan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Facing the facts of altered plasma protein binding: Do current models correctly predict changes in fraction unbound in special populations? | Journal of Pharmaceutical Sciences | Jokha Al-Qassabi Shawn Pei Feng Tan Patcharapan Phonboon Aleksandra Galetin Amin Rostami-Hodjegan | 2024/2/28 |
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA | The AAPS Journal | Lanyan Fang Yuqing Gong Andrew C Hooker Viera Lukacova Amin Rostami-Hodjegan | 2024/2/27 |
Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia | CPT: Pharmacometrics & Systems Pharmacology | Sam Mostafa Reza Rafizadeh Thomas M Polasek Chad A Bousman Amin Rostami‐Hodjegan | 2024/1/19 |
Experience Learned and Perspectives on Using Model-Integrated Evidence in the Regulatory Context for Generic Drug Products—a Meeting Report | The AAPS Journal | Eleftheria Tsakalozou Lanyan Fang Youwei Bi Michiel van den Heuvel Tausif Ahmed | 2024/1/10 |
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver | Molecular Omics | Areti-Maria Vasilogianni Sarah Alrubia Eman El-Khateeb Zubida M Al-Majdoub Narciso Couto | 2024 |
Quantitative proteomics of pharmacokinetics (PK) and pharmacodynamics (PD) targets in liver, small intestine, colon, appendiceal and peritoneal cancer | AM Vasilogianni C Demonacos Omer Aziz SA Peters J Barber | 2023 | |
On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body | Amin Rostami-Hodjegan Brahim Achour | 2023/5/27 | |
Development of 4‐Pyridoxic Acid PBPK Model to Support Biomarker‐Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease | Clinical Pharmacology & Therapeutics | Shawn Pei Feng Tan Marie‐Emilie Willemin Jan Snoeys Hong Shen Amin Rostami‐Hodjegan | 2023/12 |
Pharmacokinetics under the COVID‐19 storm | British Journal of Clinical Pharmacology | Venkatesh Pilla Reddy Eman El‐Khateeb Heeseung Jo Natalie Giovino Emily Lythgoe | 2020/1 |
Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future … | Robert Hermann Amin Rostami‐Hodjegan Ping Zhao Isabelle Ragueneau‐Majlessi | 2023/5 | |
Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn’s Disease Patients through PBPK Modeling | Pharmaceutics | Chunyan Han Tiancheng Sun Siri Kalyan Chirumamilla Frederic Y Bois Mandy Xu | 2023/8/30 |
Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc receptor (FcRn) in human tissues and implications for pharmacokinetic … | European Journal of Pharmaceutical Sciences | Jill Barber Zubida M Al-Majdoub Narciso Couto Martyn Howard Yasmine Elmorsi | 2023/3/1 |
Harnessing the Power of Physiologically Based Pharmacokinetic Modeling to Explore Potential Discordance between in vitro Dissolution, Local Gut vs Systemic Bioequivalence in … | Chunyan Han Tiancheng Sun Sirikalyan Chirumamilla Frederic Bois Mandy Xu | 2023/8/4 | |
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis | Frontiers in Oncology | Areti-Maria Vasilogianni Zubida M Al-Majdoub Brahim Achour Sheila Annie Peters Amin Rostami-Hodjegan | 2023/2/20 |
Linking in vitro–in vivo extrapolations with physiologically based modeling to inform drug and formulation development | Rodrigo Cristofoletti Amin Rostami‐Hodjegan | 2023/8 | |
Delineating gene–environment effects using virtual twins of patients treated with clozapine | CPT: Pharmacometrics & Systems Pharmacology | Sam Mostafa Thomas M Polasek Chad Bousman Amin Rostami‐Hodjegan Leslie J Sheffield | 2023/2 |
In‐depth analysis of patterns in selection of different physiologically‐based pharmacokinetic modeling tools: Part II—Assessment of model reusability and comparison between … | Biopharmaceutics & Drug Disposition | Hamza Khaled Abdelmajed Aldibani Arham Jamaal Rajput Amin Rostami‐Hodjegan | 2023/8 |
The Interplay Between Drug Release and Intestinal Gut‐Wall Metabolism | Oral Drug Delivery for Modified Release Formulations | Adam S Darwich Oliver J Hatley Andrés Olivares‐Morales Farzaneh Salem Alison Margolskee | 2022/4/20 |
Methods and apparatus for generating a virtual model of xenobiotic exposure using transcriptomics analysis of liquid biopsy samples | 2022/7/7 | ||
Effect of chronic kidney disease on the renal secretion via organic anion transporters 1/3: implications for physiologically‐based pharmacokinetic modeling and dose adjustment | Clinical Pharmacology & Therapeutics | Shawn Pei Feng Tan Daniel Scotcher Amin Rostami‐Hodjegan Aleksandra Galetin | 2022/9 |
Co-Authors
